SNP-GF-012
SNP-GF-012
SNP-GF-012
^(ValidationDate)
Yes
1
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 1/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 2/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 3/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
4.2 Most important symptoms and effects, both acute and delayed
There are no data available on the mixture itself. The mixture has been assessed following the conventional method
of the CLP Regulation (EC) No 1272/2008 and is classified for toxicological properties accordingly. See Sections 2
and 3 for details.
Exposure to component solvent vapour concentrations in excess of the stated occupational exposure limit may result
in adverse health effects such as mucous membrane and respiratory system irritation and adverse effects on the
kidneys, liver and central nervous system. Symptoms and signs include headache, dizziness, fatigue, muscular
weakness, drowsiness and, in extreme cases, loss of consciousness.
Solvents may cause some of the above effects by absorption through the skin. Repeated or prolonged contact with
the mixture may cause removal of natural fat from the skin, resulting in non-allergic contact dermatitis and absorption
through the skin.
If splashed in the eyes, the liquid may cause irritation and reversible damage.
Ingestion may cause nausea, diarrhea and vomiting.
This takes into account, where known, delayed and immediate effects and also chronic effects of components from
short-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye contact.
Based on the properties of the epoxy constituent(s) and considering toxicological data on similar mixtures, this
mixture may be a skin sensitiser and an irritant. It contains low molecular weight epoxy constituents which are
irritating to eyes, mucous membrane and skin. Repeated skin contact may lead to irritation and to sensitisation,
possibly with cross-sensitisation to other epoxies. Skin contact with the mixture and exposure to spray mist and
vapour should be avoided.
Contains epoxy resin (MW ≤ 700), epoxy resin (MW 700-1200), hydrocarbons, C9-unsaturated, polymerized. May
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 4/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
4.3 Indication of any immediate medical attention and special treatment needed
Notes to physician : Treat symptomatically. Contact poison treatment specialist immediately if large
quantities have been ingested or inhaled.
Specific treatments : No specific treatment.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 5/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
6.2 Environmental : Avoid dispersal of spilt material and runoff and contact with soil, waterways, drains
precautions and sewers. Inform the relevant authorities if the product has caused environmental
pollution (sewers, waterways, soil or air). Water polluting material. May be harmful
to the environment if released in large quantities. Collect spillage.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 6/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 7/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 8/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 10/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 11/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Exposure to component solvent vapour concentrations in excess of the stated occupational exposure limit may result
in adverse health effects such as mucous membrane and respiratory system irritation and adverse effects on the
kidneys, liver and central nervous system. Symptoms and signs include headache, dizziness, fatigue, muscular
weakness, drowsiness and, in extreme cases, loss of consciousness.
Solvents may cause some of the above effects by absorption through the skin. Repeated or prolonged contact with
the mixture may cause removal of natural fat from the skin, resulting in non-allergic contact dermatitis and absorption
through the skin.
If splashed in the eyes, the liquid may cause irritation and reversible damage.
Ingestion may cause nausea, diarrhea and vomiting.
This takes into account, where known, delayed and immediate effects and also chronic effects of components from
short-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye contact.
Based on the properties of the epoxy constituent(s) and considering toxicological data on similar mixtures, this
mixture may be a skin sensitiser and an irritant. It contains low molecular weight epoxy constituents which are
irritating to eyes, mucous membrane and skin. Repeated skin contact may lead to irritation and to sensitisation,
possibly with cross-sensitisation to other epoxies. Skin contact with the mixture and exposure to spray mist and
vapour should be avoided.
Contains epoxy resin (MW ≤ 700), epoxy resin (MW 700-1200), hydrocarbons, C9-unsaturated, polymerized. May
produce an allergic reaction.
Acute toxicity
Product/ingredient name Result Species Dose Exposure
epoxy resin (MW ≤ 700) LD50 Dermal Rabbit 20 g/kg -
LD50 Oral Mouse 15600 mg/kg -
xylene LC50 Inhalation Vapour Rat 20 mg/l 4 hours
LD50 Oral Rat 4300 mg/kg -
TDLo Dermal Rabbit 4300 mg/kg -
ethylbenzene LC50 Inhalation Vapour Rat - Male 17.8 mg/l 4 hours
LD50 Dermal Rabbit >5000 mg/kg -
LD50 Oral Rat 3500 mg/kg -
benzyl alcohol LD50 Oral Rat 1230 mg/kg -
1-methoxy-2-propanol LD50 Dermal Rabbit 13 g/kg -
LD50 Oral Rat 6600 mg/kg -
hydrocarbons, LD50 Dermal Rat >2000 mg/kg -
C9-unsaturated,
polymerized
LD50 Oral Rat >2000 mg/kg -
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 12/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 13/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
The mixture has been assessed following the summation method of the CLP Regulation (EC) No 1272/2008 and is
classified for eco-toxicological properties accordingly. See Sections 2 and 3 for details.
Product/ingredient name Result Species Exposure
epoxy resin (MW ≤ 700) Acute EC50 1.4 mg/l Daphnia 48 hours
Acute LC50 3.1 mg/l Fish - pimephales promelas 96 hours
Chronic NOEC 0.3 mg/l Fish 21 days
xylene Acute LC50 8500 μg/l Marine water Crustaceans - Daggerblade 48 hours
grass shrimp - Palaemonetes
pugio
Acute LC50 13400 μg/l Fresh water Fish - Fathead minnow - 96 hours
Pimephales promelas
titanium dioxide Acute LC50 3 mg/l Fresh water Crustaceans - Water flea - 48 hours
Ceriodaphnia dubia - Neonate
Acute LC50 6.5 mg/l Fresh water Daphnia - Water flea - Daphnia 48 hours
pulex - Neonate
Acute LC50 >1000000 μg/l Marine Fish - Mummichog - Fundulus 96 hours
water heteroclitus
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 14/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 15/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
14.6 Special precautions for : Transport within user’s premises: always transport in closed containers that are
user upright and secure. Ensure that persons transporting the product know what to do in
the event of an accident or spillage.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 17/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 18/19
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Penguard Express ZP Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 11.04.2023 Version : 1.03 19/19